Highlighting Exosome-Driven Therapeutic Mechanisms of Deramiocel, an Allogeneic Cardiac-Derived Cell Therapy
9:00 am - Wednesday 23rd September 2026
- Exploring recent update of deramiocel Phase 3 trial
- Reviewing direct evidence deramiocel exosome homing to skeletal muscle
- Understanding MOA of exosome on anti-fibrosis, anti-inflammatory and potential targeting mechanism